upc-image-aug-27

F. JIMENEZ MECA/shutterstock.com

30 November 2016Big Pharma

UK life sciences industry still uncertain despite UPC ratification

UK life sciences organisations are still uncertain about the implications of Britain’s departure from the EU, despite welcoming the announcement that the UK will ratify the Unified Patent Court (UPC) Agreement.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Preventative IP for preventative pharma healthcare

Court denies Regeneron bid to halt copy of blockbuster eye drug

Interview: Klaus Grabinski, UPC Court of Appeal president

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Dexcom suffers second patent revocation at hands of UPC